Haemodialysis – Other

J LI1,2, K MCNICHOLAS1,2,  K TORPEY1, L THORBURN1,  C DELANEY3,  A ROWLAND4, J GLEADLE1,2 1Dept of Renal Medicine, Flinders Medical Centre, Sturt Road, Bedford Park, Australia, 2College of Medicine and Public Health, Flinders University, Bedford Park, Australia, 3Dept of Vascular...
S BAHCECI1, M CHAN1 1St George Hospital , Sydney, Australia Aim: To examine the effectiveness of supplemental Intradialytic Parenteral Nutrition (IDPN) on nutritional outcomes of malnourished haemodialysis (HD) patients. Background: IDPN has been demonstrated in the literature to be a feasible...
A FLAVELL1, S COHNEY1,2, C NELSON1,2 1Western Health, , Australia, 2The University of Melbourne, , Australia Background: Metformin is the initial recommended glucose lowering agent in type two diabetes mellitus, and one of the most commonly prescribed medications in Australia....
W SYAMSURI1, M RUDIANSYAH2, R ROESLI1, A MARTAKUSUMAH1, R SUPRIYADI1, R BANDIARA1 1Division of Nephrology & Hypertension, Departement of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran/Hasan Sadikin Hospital , Bandung, Indonesia, 2Division of Nephrology & Hypertension, Departement of Internal Medicine,...
K  TIRUMALA ECHAMPATI1, R SINGER1 1Canberra Hospital, Phillip, Australia Background: There are safety and efficacy concerns surrounding use of warfarin use in haemodialysis patients. Efficacy of warfarin for stroke prevention in dialysis patients is controversial. Warfarin is associated with complications...
I MERTHA1, H PRASANTO2, I KUSWADI3 1Sarjito Hospital, Yogyakarta, Indonesia, 2Sardjito Hospital, Yogyakarta, Indonesia, 3Sardjito Hospital, Yogyakarta, Indonesia Background. Heart failure (HF) is highly prevalent and associated with high mortality in hemodialysis patients. We studied cardiac dysfunction and related factors...
I MERTHA1, H PRASANTO2, I KUSWADI3 1Sarjito Hospital, Yogyakarta, Indonesia, 2Sarjito Hospital, Yogyakarta, Indonesia, 3Sarjito Hospital, Yogyakarta, Indonesia Background. Heart failure (HF) is highly prevalent and associated with high mortality in hemodialysis patients. We studied  cardiac dysfunction and related factors...
J CHIMYONG1 1Peninsula Health , Frankston, Australia Aim: To improve the management of the symptom burden in haemodialysis patients through evaluation of IPOS renal tool. Background: Patients receiving haemodialysis treatment experience significant symptom burden that is often undetected and hence...
N ABEYSEKERA1, J REYNOLDS2, R FENTON3, T BATTAGLINI-SMITH4, R MACE4, M JOSE1,3 1School of Medicine, Hobart, Australia, 2North West Renal Satellite Unit, Burnie, Australia, 3Southern Tasmania Renal Unit, Hobart, Australia, 4Northern Tasmania Renal Unit, Launceston, Australia Aim : The Green...
D SENEVIRATNE EPA1, K BARRACLOUGH1, A WHITE1 1The Royal Melbourne Hospital, Parkville, Australia Aim: The aim of this study was to audit and compare waste generation and disposal practices and costs within two haemodialysis units in Melbourne. Background: Dialysis has among...
Recent Comments
    Categories